Prevention of benign paroxysmal positional vertigo with vitamin D supplementation
- 1 September 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 95 (9), e1117-e1125
- https://doi.org/10.1212/wnl.0000000000010343
Abstract
Objective To assess the effect of vitamin D and calcium supplementation in preventing recurrences of benign paroxysmal positional vertigo (BPPV). Methods We performed an investigator-initiated, blinded-outcome assessor, parallel, multicenter, randomized controlled trial in 8 hospitals between December 2013 and May 2017. Patients with confirmed BPPV were randomly assigned to the intervention (n = 518) or the observation (n = 532) group after successful treatment with canalith repositioning maneuvers. The primary outcome was the annual recurrence rate (ARR). Patients in the intervention group had taken vitamin D 400 IU and 500 mg of calcium carbonate twice a day for 1 year when serum vitamin D level was lower than 20 ng/mL. Patients in the observation group were assigned to follow-ups without further vitamin D evaluation or supplementation. Results The intervention group showed a reduction in the ARR (0.83 [95% confidence interval (CI), 0.74–0.92] vs 1.10 [95% CI, 1.00–1.19] recurrences per 1 person-year) with an incidence rate ratio of 0.76 (95% CI, 0.66–0.87, p < 0.001) and an absolute rate ratio of −0.27 (−0.40 to −0.14) from intention-to-treat analysis. The number needed to treat was 3.70 (95% CI, 2.50–7.14). The proportion of patients with recurrence was also lower in the intervention than in the observation group (37.8 vs 46.7%, p = 0.005). Conclusions Supplementation of vitamin D and calcium may be considered in patients with frequent attacks of BPPV, especially when serum vitamin D is subnormal. Classification of evidence This study provides Class III evidence that for patients with BPPV, vitamin D and calcium supplementation reduces recurrences of BPPV.This publication has 34 references indexed in Scilit:
- Negative association between treated osteoporosis and benign paroxysmal positional vertigo in womenThe Journal of Laryngology & Otology, 2009
- Relationship Between Bone Mineral Density and Clinical Features in Women With Idiopathic Benign Paroxysmal Positional VertigoOtology & Neurotology, 2009
- Ultrastructural Changes in Otoconia of Osteoporotic RatsAudiology and Neurotology, 2008
- Epidemiology of benign paroxysmal positional vertigo: a population based studyJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Benign paroxysmal positioning vertigo: A long-term follow-up (6–17 years) of 125 patientsActa Oto-Laryngologica, 2006
- Vitamin D upregulates expression of ECaC1 mRNA in semicircular canalBiochemical and Biophysical Research Communications, 2005
- Short‐ and Long‐Term Outcomes of Canalith Repositioning for Benign Paroxysmal Positional VertigoOtolaryngology -- Head and Neck Surgery, 2000
- Benign Paroxysmal Positional VertigoThe New England Journal of Medicine, 1999
- Free‐Floating endolymph particles: A new operative finding during posterior semicircular canal occlusionThe Laryngoscope, 1992
- Incorporation Of Radioactive Calcium Into Otolithic Membranes And Middle Ear Ossicles Of The GerbilActa Oto-Laryngologica, 1975